Medtronic (MDT) Liabilities and Shareholders Equity (2016 - 2026)
Medtronic's Liabilities and Shareholders Equity history spans 12 years, with the latest figure at $91.5 billion for Q1 2026.
- For Q1 2026, Liabilities and Shareholders Equity rose 1.68% year-over-year to $91.5 billion; the TTM value through Jan 2026 reached $365.5 billion, up 1.6%, while the annual FY2025 figure was $91.7 billion, 1.89% up from the prior year.
- Liabilities and Shareholders Equity for Q1 2026 was $91.5 billion at Medtronic, roughly flat from $91.3 billion in the prior quarter.
- Across five years, Liabilities and Shareholders Equity topped out at $94.1 billion in Q1 2023 and bottomed at $89.7 billion in Q3 2024.
- The 5-year median for Liabilities and Shareholders Equity is $90.9 billion (2023), against an average of $91.1 billion.
- The largest annual shift saw Liabilities and Shareholders Equity decreased 5.62% in 2022 before it increased 2.54% in 2023.
- A 5-year view of Liabilities and Shareholders Equity shows it stood at $93.2 billion in 2022, then decreased by 3.38% to $90.1 billion in 2023, then dropped by 0.05% to $90.0 billion in 2024, then rose by 1.45% to $91.3 billion in 2025, then rose by 0.15% to $91.5 billion in 2026.
- Per Business Quant, the three most recent readings for MDT's Liabilities and Shareholders Equity are $91.5 billion (Q1 2026), $91.3 billion (Q4 2025), and $91.0 billion (Q3 2025).